SK Bio Begins New Coronavirus Vaccine Development Using Versatile Platform

 
• By Jung Won Shin

Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.

Vaccine_Development_SK
New Versatile Platform Technology Aimed At Virus Outbreaks • Source: SK Bioscience

More from South Korea

More from Focus On Asia